Derfuss, Tobias’s team published research in Lancet Neurology in 2020-04-30 | 112-63-0

Lancet Neurology published new progress about Brain. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, SDS of cas: 112-63-0.

Derfuss, Tobias; Mehling, Matthias; Papadopoulou, Athina; Bar-Or, Amit; Cohen, Jeffrey A.; Kappos, Ludwig published the artcile< Advances in oral immunomodulating therapies in relapsing multiple sclerosis>, SDS of cas: 112-63-0, the main research area is review multiple sclerosis oral immunomodulating therapy.

A review. Although these immunomodulating therapies are all orally administered, and thus convenient for patients, they have different modes of action. These distinct mechanisms of action allow better adaptation of treatments according to individual comorbidities and offer different mechanisms of treatment such as inhibition of immune cell trafficking vs. immune cell depletion, thereby substantially expanding the available treatment options. Evobrutinib reduced MRI activity in a phase 2 trial, and a phase 3 trial is underway, in patients with relapsing multiple sclerosis. Diroximel fumarate is metabolised to monomethyl fumarate, the active metabolite of di-Me fumarate, reduces circulating lymphocytes and modifies the activation profile of monocytes, and is being tested in this disease with the aim to improve gastrointestinal tolerability. With new modes of action introduced to the treatment of multiple sclerosis, the question of how to select and sequence different treatments in individual patients arises. Balancing risks with the expected efficacy of disease-modifying therapies will still be key for treatment selection. This treatment scheme might lead to higher efficacy but also to new safety concerns. These sequential treatments were largely excluded in phase 2 and 3 trials; therefore, monitoring both short-term and long-term effects of sequential disease-modifying therapies in phase 4 studies, cohort studies, and registries will be necessary.

Lancet Neurology published new progress about Brain. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, SDS of cas: 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Chenna, Bala C’s team published research in Journal of Medicinal Chemistry in 2020-03-26 | 112-63-0

Journal of Medicinal Chemistry published new progress about Chagas disease. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Safety of (9Z,12Z)-Methyl octadeca-9,12-dienoate.

Chenna, Bala C.; Li, Linfeng; Mellott, Drake M.; Zhai, Xiang; Siqueira-Neto, Jair L.; Calvet Alvarez, Claudia; Bernatchez, Jean A.; Desormeaux, Emily; Alvarez Hernandez, Elizabeth; Gomez, Jana; McKerrow, James H.; Cruz-Reyes, Jorge; Meek, Thomas D. published the artcile< Peptidomimetic vinyl heterocyclic inhibitors of cruzain effect antitrypanosomal activity>, Safety of (9Z,12Z)-Methyl octadeca-9,12-dienoate, the main research area is peptidomimetic vinyl heterocyclic inhibitor cruzain preparation antitrypanosomal structure activity; PVHI cruzain substrate dipeptide enzyme kinetic mol docking; drug design computer assisted; Wittig reaction Horner Wadsworth Emmons amino acid peptide coupling.

Cruzain, an essential cysteine protease of the parasitic protozoan, Trypanosoma cruzi, is an important drug target for Chagas disease. We describe here a new series of reversible but time-dependent inhibitors of cruzain, composed of a dipeptide scaffold appended to vinyl heterocycles meant to provide replacements for the irreversible reactive “”warheads”” of vinyl sulfone inactivators of cruzain. Peptidomimetic vinyl heterocyclic inhibitors (PVHIs) containing Cbz-Phe-Phe/homoPhe scaffolds with vinyl-2-pyrimidine, vinyl-2-pyridine, and vinyl-2-(N-methyl)-pyridine groups conferred reversible, time-dependent inhibition of cruzain (Ki* = 0.1-0.4μM). These cruzain inhibitors exhibited moderate to excellent selectivity vs. human cathepsins B, L, and S and showed no apparent toxicity to human cells but were effective in cell cultures of Trypanosoma brucei brucei (EC50 = 1-15μM) and eliminated T. cruzi in infected murine cardiomyoblasts (EC50 = 5-8μM). PVHIs represent a new class of cruzain inhibitors that could progress to viable candidate compounds to treat Chagas disease and human sleeping sickness.

Journal of Medicinal Chemistry published new progress about Chagas disease. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Safety of (9Z,12Z)-Methyl octadeca-9,12-dienoate.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Zhao, Haoyang’s team published research in Translational Psychiatry in 2022-12-31 | 112-63-0

Translational Psychiatry published new progress about Acrobacter (lekithochrous). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Reference of 112-63-0.

Zhao, Haoyang; Jin, Kangyu; Jiang, Chaonan; Pan, Fen; Wu, Jing; Luan, Honglin; Zhao, Zhiyong; Chen, Jingkai; Mou, Tingting; Wang, Zheng; Lu, Jing; Lu, Shaojia; Hu, Shaohua; Xu, Yi; Huang, Manli published the artcile< A pilot exploration of multi-omics research of gut microbiome in major depressive disorders>, Reference of 112-63-0, the main research area is major depressive disorder gut microbiome metabolism immunity brain.

The pathophysiol. of major depressive disorder (MDD) remains obscure. Recently, the microbiota-gut-brain (MGB) axiss role in MDD has an increasing attention. However, the specific mechanism of the multi-level effects of gut microbiota on host metabolism, immunity, and brain structure is unclear. Multi-omics approaches based on the anal. of different body fluids and tissues using a variety of anal. platforms have the potential to provide a deeper understanding of MGB axis disorders. Therefore, the data of metagenomics, metabolomic, inflammatory factors, and MRI scanning are collected from the two groups including 24 drug-naive MDD patients and 26 healthy controls (HCs). Then, the correlation anal. is performed in all omics. The results confirmed that there are many markedly altered differences, such as elevated Actinobacteria abundance, plasma IL-1β concentration, lipid, vitamin, and carbohydrate metabolism disorder, and diminished gray matter volume (GMV) of inferior frontal gyrus (IFG) in the MDD patients. Notably, three kinds of discriminative bacteria, Ruminococcus bromii, Lactococcus chungangensis, and Streptococcus gallolyticus have an extensive correlation with metabolome, immunol., GMV, and clin. symptoms. All three microbiota are closely related to IL-1β and lipids (as an example, phosphoethanolamine (PEA)). Besides, Lactococcus chungangensis is neg. related to the GMV of left IFG. Overall, this study demonstrate that the effects of gut microbiome exert in MDD is multifactorial.

Translational Psychiatry published new progress about Acrobacter (lekithochrous). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Reference of 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Li, Sha’s team published research in Youji Huaxue in 2020 | 112-63-0

Youji Huaxue published new progress about Lactonization. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Name: (9Z,12Z)-Methyl octadeca-9,12-dienoate.

Li, Sha; Xu, Jiayu; Luo, Xian; Yang, Wenhan; Yao, Changsheng published the artcile< Efficient N-heterocyclic carbene-catalyzed cascade synthesis of functionalized naphthopyranone>, Name: (9Z,12Z)-Methyl octadeca-9,12-dienoate, the main research area is heterocyclic carbene catalyst naphthopyranone cascade reaction preparation.

An efficient N-heterocyclic carbene(NHC)-catalyzed “”Michael-Michael-Lactonization”” cascade process involving chalcone derivatives and α-bromoenals for the syntheses of functionalized naphthopyranones was disclosed. This approach was qualified with good yields, readily available starting materials and mild reaction conditions.

Youji Huaxue published new progress about Lactonization. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Name: (9Z,12Z)-Methyl octadeca-9,12-dienoate.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Xuan, Yang’s team published research in Theranostics in 2022 | 347174-05-4

Theranostics published new progress about Antitumor agents. 347174-05-4 belongs to class esters-buliding-blocks, and the molecular formula is C15H22N2O2, Electric Literature of 347174-05-4.

Xuan, Yang; Wang, Huogang; Yung, Mingo Mh; Chen, Fushun; Chan, Wai-Sun; Chan, Yau-Sang; Tsui, Stephen Kw; Ngan, Hextan Ys; Chan, Karen K. L.; Chan, David W. published the artcile< SCD1/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells>, Electric Literature of 347174-05-4, the main research area is CAY10566 sc26196 cisplatin anticancer agent prognosis ferroptosis ovarian cancer; lipid desaturases; lipid metabolism; ovarian cancer; oxidative stress; peritoneal metastases.

Malignant ascites in peritoneal metastases is a lipid-enriched microenvironment and is frequently involved in the poor prognosis of epithelial ovarian cancer (EOC). However, the detailed mechanisms underlying ovarian cancer (OvCa) cells dictating their lipid metabolic activities in promoting tumor progression remain elusive. The omental conditioned medium (OCM) was established to imitate the omental or ascites microenvironment. Mass spectrometry, RT-qPCR, IHC, and western blot assays were applied to evaluate human fatty acid desaturases expressions and activities. Pharmaceutical inhibition and genetic ablation of SCD1/FADS2 were performed to observe the oncogenic capacities. RNA sequencing, lipid peroxidation, cellular iron, ROS, and Mito-Stress assays were applied to examine ferroptosis. OvCa patient-derived organoid and mouse model of peritoneal metastases were used to evaluate the combined effect of SCD1/FADS2 inhibitors with cisplatin. We found that two critical fatty acid desaturases, stearoyl-CoA desaturase-1 (SCD1) and acyl-CoA 6-desaturase (FADS2), were aberrantly upregulated, accelerating lipid metabolic activities and tumor aggressiveness of ascites-derived OvCa cells. Lipidomic anal. revealed that the elevation of unsaturated fatty acids (UFAs) was pos. associated with SCD1/FADS2 levels and the oncogenic capacities of OvCa cells. In contrast, pharmaceutical inhibition and genetic ablation of SCD1/FADS2 retarded tumor growth, cancer stem cell (CSC) formation and reduced platinum resistance. Inhibition of SCD1/FADS2 directly downregulated GPX4 and the GSH/GSSG ratio, causing disruption of the cellular/mitochondrial redox balance and subsequently, iron-mediated lipid peroxidation and mitochondrial dysfunction in ascites-derived OvCa cells. Combinational treatment with SCD1/FADS2 inhibitors and cisplatin synergistically repressed tumor cell dissemination, providing a promising chemotherapeutic strategy against EOC peritoneal metastases.

Theranostics published new progress about Antitumor agents. 347174-05-4 belongs to class esters-buliding-blocks, and the molecular formula is C15H22N2O2, Electric Literature of 347174-05-4.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Rana, Qurrat Ul Ain’s team published research in Biofuels in 2022 | 112-63-0

Biofuels published new progress about Biocatalysis. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Electric Literature of 112-63-0.

Rana, Qurrat Ul Ain; Irfan, Muhammad; Ahmed, Safia; Hasan, Fariha; Shah, Aamer Ali; Khan, Samiullah; Ur Rehman, Fazal; Khan, Haji; Ju, Meiting; Li, Weizun; Badshah, Malik published the artcile< Bio-catalytic transesterification of mustard oil for biodiesel production>, Electric Literature of 112-63-0, the main research area is biodiesel mustard oil fatty acid mathyl ester biocatalysis transesterification.

The depletion of non-renewable fossil fuels and a surge in their prices have led researchers to seek alternative, renewable energy sources; among them, biodiesel is a good option, especially in the ever-growing global transport sector. Mustard oil is a potential feedstock for biodiesel production, and because it is non-edible it avoids the food vs. fuel feud. Biocatalytic transesterification of mustard oil for biodiesel production makes this process cost efficient, environmentally friendly and sustainable. In the current study, Pseudomanas aeruginosa Q8 KX12304-mediated transesterification of mustard oil was carried out. The parameters for the transesterification reaction were statistically optimized using Plackett-Burman and central composite design. The highest biodiesel volumetric yield obtained was 100% at optimized conditions. The quality of biodiesel was confirmed using gas chromatog.-mass spectrometry (GCMS) and the produced biodiesel was found to meet the quality standards specified by American Society for Testing and Materials (ASTM) and EU-14103. The fatty acid Me ester contents of the biodiesel produced were erucic acid Me esters (48.2%), palmitic acid Me esters (11.8%), oleic acid Me esters (10.6%), linolenic acid Me esters (10.3%), linoleic acid Me esters (9.1%) and stearic acid Me esters (8%). To the best of our knowledge, this is the first study to report transesterification of mustard oil via biocatalysis.

Biofuels published new progress about Biocatalysis. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Electric Literature of 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Ling, Kenneth B’s team published research in Chemical Communications (Cambridge, United Kingdom) in 2011-01-07 | 112-63-0

Chemical Communications (Cambridge, United Kingdom) published new progress about [4+2] Cycloaddition reaction. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, SDS of cas: 112-63-0.

Ling, Kenneth B.; Smith, Andrew D. published the artcile< α-Aroyloxyaldehydes: scope and limitations as alternatives to α-haloaldehydes for NHC-catalyzed redox transformations>, SDS of cas: 112-63-0, the main research area is alpha aryloxyaldehyde NHC catalyst redox esterification cycloaddition.

α-Aroyloxyaldehydes are readily prepared bench stable synthetic intermediates. Their ability to act as α-haloaldehyde surrogates for NHC-promoted redox esterifications and in [4+2] cycloadditions is described.

Chemical Communications (Cambridge, United Kingdom) published new progress about [4+2] Cycloaddition reaction. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, SDS of cas: 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Auld, Andrew F’s team published research in BMC Medicine in 2020-12-31 | 112-63-0

BMC Medicine published new progress about Antiviral agents. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Recommanded Product: (9Z,12Z)-Methyl octadeca-9,12-dienoate.

Auld, Andrew F.; Agizew, Tefera; Mathoma, Anikie; Boyd, Rosanna; Date, Anand; Pals, Sherri L.; Serumola, Christopher; Mathebula, Unami; Alexander, Heather; Ellerbrock, Tedd V.; Rankgoane-Pono, Goabaone; Pono, Pontsho; Shepherd, James C.; Fielding, Katherine; Grant, Alison D.; Finlay, Alyssa published the artcile< Effect of tuberculosis screening and retention interventions on early antiretroviral therapy mortality in Botswana: a stepped-wedge cluster randomized trial>, Recommanded Product: (9Z,12Z)-Methyl octadeca-9,12-dienoate, the main research area is efavirenz emtricitabine nevirapine ritonavir antiretroviral agent tuberculosis; Intensified tuberculosis case finding; Mortality; Tuberculosis; Xpert MTB/RIF.

Undiagnosed tuberculosis (TB) remains the most common cause of HIV-related mortality. Xpert MTB/RIF (Xpert) is being rolled out globally to improve TB diagnostic capacity. However, previous Xpert impact trials have reported that health system weaknesses blunted impact of this improved diagnostic tool. During phased Xpert rollout in Botswana, we evaluated the impact of a package of interventions comprising (1) addnl. support for intensified TB case finding (ICF), (2) active tracing for patients missing clinic appointments to support retention, and (3) Xpert replacing sputum-smear microscopy, on early (6-mo) antiretroviral therapy (ART) mortality. At 22 clinics, ART enrollees > 12 years old were eligible for inclusion in three phases: a retrospective standard of care (SOC), prospective enhanced care (EC), and prospective EC plus Xpert (EC+X) phase. EC and EC+X phases were implemented as a stepped-wedge trial. Participants in the EC phase received SOC plus components 1 (strengthened ICF) and 2 (active tracing) of the intervention package, and participants in the EC+X phase received SOC plus all three intervention package components. Primary and secondary objectives were to compare all-cause 6-mo ART mortality between SOC and EC+X and between EC and EC+X phases, resp. We used adjusted analyses, appropriate for study design, to control for baseline differences in individual-level factors and intra-facility correlation. We enrolled 14,963 eligible patients: 8980 in SOC, 1768 in EC, and 4215 in EC+X phases. Median age of ART enrollees was 35 and 64% were female. Median CD4 cell count was lower in SOC than subsequent phases (184/μL in SOC, 246/μL in EC, and 241/μL in EC+X). By 6 mo of ART, 461 (5.3%) of SOC, 54 (3.2%) of EC, and 121 (3.0%) of EC+X enrollees had died. Compared with SOC, 6-mo mortality was lower in the EC+X phase (adjusted hazard ratio, 0.77; 95% confidence interval, 0.61-0.97, p = 0.029). Compared with EC enrollees, 6-mo mortality was similar among EC+X enrollees. Interventions to strengthen ICF and retention were associated with lower early ART mortality. This new evidence highlights the need to strengthen ICF and retention in many similar settings. Similar to other trials, no addnl. mortality benefit of replacing sputum-smear microscopy with Xpert was observed

BMC Medicine published new progress about Antiviral agents. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Recommanded Product: (9Z,12Z)-Methyl octadeca-9,12-dienoate.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Catalan, Javier’s team published research in Chemica Scripta in 1984 | 112-63-0

Chemica Scripta published new progress about Acidity. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Safety of (9Z,12Z)-Methyl octadeca-9,12-dienoate.

Catalan, Javier; De Paz, Jose Luis G.; Yanez, Manuel; Elguero, Jose published the artcile< The azoles: a theoretical study>, Safety of (9Z,12Z)-Methyl octadeca-9,12-dienoate, the main research area is MO azole; protonation azole; dipole moment azole; tautomerism azole.

Ab initio calculations were reported for 35 azoles (neutral mols. and protonated azolium salts) based on INDO optimized geometries. Calculated dipole moments agreed with measured values. Protonation sites (most basic N atoms) were determined from calculated protonation energies and N lone pair changes. Linear relations between exptl. aqueous basicity and calculated protonation energies for N-methylazoles and between exptl. aqueous acidity for N-unsubstituted azoles and the charge of the NH H atom, were observed Tautomerism of the triazoles and tetrazoles were discussed.

Chemica Scripta published new progress about Acidity. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Safety of (9Z,12Z)-Methyl octadeca-9,12-dienoate.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Ding, Pei-Gang’s team published research in Chemical Science in 2020 | 112-63-0

Chemical Science published new progress about Alkanes, nitro Role: PRP (Properties), RCT (Reactant), SPN (Synthetic Preparation), RACT (Reactant or Reagent), PREP (Preparation). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, SDS of cas: 112-63-0.

Ding, Pei-Gang; Zhou, Feng; Wang, Xin; Zhao, Qiu-Hua; Yu, Jin-Sheng; Zhou, Jian published the artcile< H-bond donor-directed switching of diastereoselectivity in the Michael addition of α-azido ketones to nitroolefins>, SDS of cas: 112-63-0, the main research area is nitroalkene azido ketone bifunctional chiral amide catalyst Michael addition; azido nitroalkanone preparation diastereoselective enantioselective.

The potency of H-bond donors as the governing factor to tune diastereoselectivity in a highly diastereoselective switchable enantioselective Michael addition of α-azido ketones to nitroolefins was reported. While a newly developed bifunctional tertiary amine, phosphoramide, preferentially afforded syn-adducts, an analogous squaramide catalyst selectively gave anti-adducts. The resulting multifunctional tertiary azides were converted to spiro-pyrrolidines with four continuous stereocenters in a one-pot operation. Mechanistic studies casted light on the control of diastereoselectivity by H-bond donors. While the squaramide-catalyzed reaction proceeded with a transition state with both squaramide N-H bonds binding to an enolate intermediate, an unprecedented model was proposed for the phosphoramide-mediated reaction wherein an amide N-H bond and an alkylammonium ion formed in-situ interacted with nitroolefins, with the enolate stabilized by non-classical C-H···O hydrogen-bonding interactions.

Chemical Science published new progress about Alkanes, nitro Role: PRP (Properties), RCT (Reactant), SPN (Synthetic Preparation), RACT (Reactant or Reagent), PREP (Preparation). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, SDS of cas: 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics